AbbVie Biotech Innovators Award Launches in Quebec
In a remarkable initiative to bolster life sciences innovation, AbbVie has partnered with adMare BioInnovations to unveil the AbbVie Biotech Innovators Award. This national competition underscores AbbVie's dedication to nurturing a robust biotech ecosystem in Quebec.
Supporting Early-Stage Biotechnology Startups
The AbbVie Biotech Innovators Award is specifically designed to support early-stage biotechnology companies that have the potential to develop transformative therapies. The focus includes critical therapeutic areas such as immunology, oncology, neuroscience, eye care, and aesthetics.
What the Award Offers
One selected biotechnology startup will receive significant support, including a full year of complimentary laboratory and office space at the adMare Innovation Centre in Montreal. This location provides access to shared equipment and essential services at no cost. Additionally, the winner will benefit from guidance and mentorship from AbbVie’s scientific and business executives.
Expert Views
“This award aligns perfectly with adMare’s mission of fostering sustainable, globally competitive life science companies in Canada,” said Gordon C. McCauley, President and CEO of adMare BioInnovations. “We are thrilled to partner with AbbVie in providing key resources to the next biotech leader in Canada, enabling them to focus on important technological advancements for greater health impacts.”
Abbie's Mission and Commitment
Rami Fayed, Vice President and General Manager of AbbVie Canada, expressed enthusiasm about the award’s potential. “We are excited to support this initiative, which is a testament to AbbVie’s commitment to fostering innovation in life sciences and addressing some of the most pressing health challenges facing patients today.”
Application Process
The call for applications is now open, with submissions accepted until February 20, 2026. Aspiring biotech innovators are encouraged to participate and can find further information about requirements and criteria for submission.
The Impact of the Life Sciences Sector in Quebec
The life sciences and health technologies sector play a significant role in Quebec's economy, contributing $6.5 billion to the province’s GDP. These industries are instrumental in driving not just local but global advancements in health care solutions.
About AbbVie and AdMare BioInnovations
AbbVie is dedicated to discovering and delivering innovative treatments that address severe health challenges of today while preparing for future medical needs. Their work in various therapeutic areas showcases their commitment to improving lives.
AdMare BioInnovations, with its extensive experience in biotechnology, works diligently to establish strong life sciences companies and healthcare ecosystems in Canada. By providing resources like capital and infrastructure, adMare has founded numerous successful companies, significantly contributing to job creation and economic fortitude in Canada.
Frequently Asked Questions
What is the AbbVie Biotech Innovators Award?
The AbbVie Biotech Innovators Award is a national competition aimed at fostering innovation and supporting early-stage biotechnology startups in Quebec.
Who can apply for the award?
Early-stage biotechnology startups with innovative solutions in therapeutic areas such as immunology, oncology, and neuroscience are encouraged to apply.
What does the winner receive?
The winning biotech company will receive a year of complimentary lab and office space, access to shared equipment, and mentorship from AbbVie executives.
When is the application deadline?
Applications will be accepted until February 20, 2026.
How does this award benefit the life sciences sector?
This award aims to enhance the biotech ecosystem, providing startups the resources and guidance needed to innovate and thrive in the competitive life sciences field.
